Immunogen Inc (IMGN) Return on Assets ROA from the third quarter of 2023 to third quarter of 2022 and for the year 2023, Average High and Low, Fundamental Ratios from Sep 30 2023 to Sep 30 2022 - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Immunogen inc   (NASDAQ: IMGN)


Immunogen Inc 's ROA from the third quarter of 2023 to the third quarter of 2022 and 5 Year Period

Return on Assets, Quarterly Results, Trends, Rankings, Statistics


What is Immunogen Inc 's ROA in the third quarter of 2023?
Immunogen Inc recorded a cumulative net loss of $-74 million during 12 months ending in the third quarter of 2023, resulting in a negative return on assets (ROA) of -13.74%.

However, within the Healthcare sector 325 other companies had a higher return on assets. While Return on assets, overall ranking has advanced in the Sep 30 2023 quarter, so far to 3672, from total ROA ranking in the second quarter of 2023 at 4455.

What is ROA?


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Assets (Sep 30 2023)
III. Quarter		 (Jun 30 2023)
II. Quarter		 (Mar 31 2023)
I. Quarter		 (Dec 31 2022)
IV. Quarter		 (Sep 30 2022)
III. Quarter
Y / Y Total Assets Change 133.69 % 71.51 % -40.59 % -34.23 % 22.19 %
Y / Y Net Income Change - - - - -
Net Income (TTM) in million -74 -182 -240 -223 -201
Return On Assets (TTM) -13.74 % -43.49 % -69.53 % -56.77 % -46.04 %
IMGN's Total Ranking # 3672 # 4455 # 4931 # 5547 # 4783
Total Assets (TTM) in million 815 707 280 338 349
Seq. Total Assets Change 15.31 % 152.58 % -17.3 % -2.98 % -15.37 %
Seq. Net Income Change - - - - -

IMGN's 5 Years Annual ROA >> Back to IMGN Management Effectiveness >> Compare IMGN ROA to its Competitors


Return On Assets Company Ranking
Within: No.
Industry # 124
Sector # 326
Overall # 3611

Return On Assets Statistics
High Average Low
-13.53 %
-41.9 %
-72.33 %
(Sep 30 2023)   (Dec 31 2016)





Financial Statements
Immunogen Inc 's Assets $ 815 million IMGN's Balance sheet
Immunogen Inc 's Income $ 31 million Quarterly IMGN's Income Statement
IMGN's Income by Division See IMGN's Income by Division



Annual Return On Assets (Dec 31 2022)
FY 2022		 (Dec 31 2021)
FY 2021		 (Dec 31 2020)
FY 2020		 (Dec 31 2019)
FY 2019		 (Dec 31 2018)
FY 2018
Y / Y Total Assets Change -34.23 % -51.67 % 352.67 % -20.35 % 0.24 %
Total Assets in million 338 515 1,065 235 295
Y / Y Net Income Change - - - - -
Net Income in million -223 -139 -44 -104 -169
Annual Return On Assets -65.86 % -27.07 % -4.17 % -44.26 % -57.16 %

IMGN's 5 Years Annual ROA >> Back to IMGN Management Effectiveness >> Compare IMGN ROA to its Competitors



More Return On Assets Ratios
IMGN's' Return on Assets at Yahoo Finance
Major Pharmaceutical Preparations Industry Return On Assets Trends and Statistics
Healthcare Sector Roa Statistics
Roa Trends for overall market
IMGN's Roa Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and overall Market
Highest Ranking Return On Assets
Lowest Ranking Return On Assets
Subscribers only: Roa for IMGN's Competitors
Subscribers only: Roa for Immunogen Inc 's Suppliers
Subscribers only: Return On Assets for IMGN's Customers

You may also want to know
IMGN's Roi IMGN's Inventory Turnover Ratio IMGN's Growth Rates IMGN's Dividend Comparisons
IMGN's Profitability Ratios IMGN's Asset Turnover Ratio IMGN's Dividend Growth
IMGN's Roe IMGN's Valuation Ratios IMGN's Financial Strength Ratios IMGN's Dividend Payout Ratio



Companies with similar Return On Assets at Sep 30 2023, within Healthcare Sector ROA

Date modified: 2026-09-18T13:11:05+00:00


Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.